Thyrocare Technologies Ltd (IN:THYROCARE)
:THYROCARE
Want to see IN:THYROCARE full AI Analyst Report?
Total Valuation
Thyrocare Technologies Ltd has a market cap or net worth of ₹74.76B. The enterprise value is ₹24.54B.
Market Cap₹74.76B
Enterprise Value₹24.54B
Share Statistics
Thyrocare Technologies Ltd has 159,165,310 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding159,165,310
Owned by Insiders―
Owned by Institutions0.08%
Financial Efficiency
Thyrocare Technologies Ltd’s return on equity (ROE) is 0.28 and return on invested capital (ROIC) is 23.99%.
Return on Equity (ROE)0.28
Return on Assets (ROA)0.22
Return on Invested Capital (ROIC)23.99%
Return on Capital Employed (ROCE)0.32
Revenue Per Employee4.90M
Profits Per Employee963.02K
Employee Count1,693
Asset Turnover1.11
Inventory Turnover8.59
Valuation Ratios
The current PE Ratio of Thyrocare Technologies Ltd is 34.0. Thyrocare Technologies Ltd’s PEG ratio is -0.84.
PE Ratio34.0
PS Ratio6.69
PB Ratio9.48
Price to Fair Value9.48
Price to FCF28.40
Price to Operating Cash Flow57.74
PEG Ratio-0.84
Income Statement
In the last 12 months, Thyrocare Technologies Ltd had revenue of 8.29B and earned 1.63B in profits. Earnings per share was 10.27.
Revenue8.29B
Gross Profit4.13B
Operating Income2.03B
Pretax Income2.13B
Net Income1.63B
EBITDA2.62B
Earnings Per Share (EPS)10.27
Cash Flow
In the last 12 months, operating cash flow was 1.27B and capital expenditures -157.90M, giving a free cash flow of 1.11B billion.
Operating Cash Flow1.27B
Free Cash Flow1.11B
Free Cash Flow per Share6.99
Dividends & Yields
Thyrocare Technologies Ltd pays an annual dividend of ₹2.333, resulting in a dividend yield of 0.68%
Dividend Per Share₹2.333
Dividend Yield0.68%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.60
52-Week Price Change41.30%
50-Day Moving Average405.43
200-Day Moving Average427.38
Relative Strength Index (RSI)61.77
Average Volume (3m)56.30K
Important Dates
Thyrocare Technologies Ltd upcoming earnings date is Aug 4, 2026, TBA (Confirmed).
Last Earnings DateMay 7, 2026
Next Earnings DateAug 4, 2026
Ex-Dividend Date―
Financial Position
Thyrocare Technologies Ltd as a current ratio of 3.39, with Debt / Equity ratio of 8.66%
Current Ratio3.39
Quick Ratio2.95
Debt to Market Cap<0.01
Net Debt to EBITDA-0.07
Interest Coverage Ratio72.66
Taxes
In the past 12 months, Thyrocare Technologies Ltd has paid 500.30M in taxes.
Income Tax500.30M
Effective Tax Rate0.24
Enterprise Valuation
Thyrocare Technologies Ltd EV to EBITDA ratio is 21.11, with an EV/FCF ratio of 28.31.
EV to Sales6.67
EV to EBITDA21.11
EV to Free Cash Flow28.31
EV to Operating Cash Flow25.57
Balance Sheet
Thyrocare Technologies Ltd has ₹1.92B in cash and marketable securities with ₹246.80M in debt, giving a net cash position of ₹1.68B billion.
Cash & Marketable Securities₹1.92B
Total Debt₹246.80M
Net Cash₹1.68B
Net Cash Per Share₹10.54
Tangible Book Value Per Share₹29.88
Margins
Gross margin is 55.15%, with operating margin of 24.54%, and net profit margin of 19.67%.
Gross Margin55.15%
Operating Margin24.54%
Pretax Margin25.68%
Net Profit Margin19.67%
EBITDA Margin31.61%
EBIT Margin24.54%
Analyst Forecast
The average price target for Thyrocare Technologies Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast20.61%
EPS Growth Forecast78.25%